| 000 | 01462 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250514034622.0 | ||
| 264 | 0 | _c20021119 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a0960-894X | ||
| 024 | 7 |
_a10.1016/s0960-894x(02)00294-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBorthwick, Alan D | |
| 245 | 0 | 0 |
_aPyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry letters _cJul 2002 |
||
| 300 |
_a1719-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xchemistry |
| 650 | 0 | 4 |
_aCytomegalovirus _xenzymology |
| 650 | 0 | 4 |
_aDansyl Compounds _xchemistry |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aLactams _xblood |
| 650 | 0 | 4 |
_aProline _xanalogs & derivatives |
| 650 | 0 | 4 |
_aProtease Inhibitors _xblood |
| 650 | 0 | 4 |
_aPyrrolidines _xblood |
| 650 | 0 | 4 | _aSpectrometry, Mass, Electrospray Ionization |
| 700 | 1 | _aExall, Anne M | |
| 700 | 1 | _aHaley, Terry M | |
| 700 | 1 | _aJackson, Deborah L | |
| 700 | 1 | _aMason, Andrew M | |
| 700 | 1 | _aWeingarten, Gordon G | |
| 773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 12 _gno. 13 _gp. 1719-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-894x(02)00294-9 _zAvailable from publisher's website |
| 999 |
_c11962819 _d11962819 |
||